Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial

P. Duquette, M. Girard, L. Despault, R. Dubois, R. L. Knobler, F. D. Lublin, L. Kelley, G. S. Francis, Y. Lapierre, J. Antel, M. Freedman, S. Hum, J. I. Greenstein, B. Mishra, J. Muldoon, J. N. Whitaker, B. K. Evans, B. Layton, W. A. Sibley, J. LagunaJ. Krikawa, D. W. Paty, J. J. Oger, L. F. Kastrukoff, W. Moore, S. A. Hashimoto, W. Morrison, J. Nelson, D. S. Goodin, S. M. Massa, E. Gutteridge, B. G.W. Arnason, A. Noronha, A. T. Reder, R. Martia, G. C. Ebers, G. P.A. Rice, J. Lesaux, K. P. Johnson, H. S. Panitch, C. T. Bever, K. Conway, J. Constine, W. Lisa, S. Van den Noort, B. Weinshenker, W. Weiss, S. Reingold, A. Pachner, W. Taylor

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences